Milena Mazan

Krakow, MA 30394, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Integrated Multi-Omics and Interactome Analysis of CDK8 Inhibition Reveals Erythroid Differentiation Programs and Therapeutic Synergy with BET Blockade in AML.

Integrated Multi-Omics and Interactome Analysis of CDK8 Inhibition Reveals Erythroid Differentiation Programs and Therapeutic Synergy with BET Blockade in AML.

Journal: Cells

Published: June 28, 2026

Heme Oxygenase-1 Differentially Controls Pigmentation in Physiological and Pathological Melanogenesis.

Heme Oxygenase-1 Differentially Controls Pigmentation in Physiological and Pathological Melanogenesis.

Journal: Pigment cell & melanoma research

Published: January 15, 2026

Romaciclib, a CDK8/CDK19 inhibitor, can overcome venetoclax resistance through a combinatorial strategy.

Romaciclib, a CDK8/CDK19 inhibitor, can overcome venetoclax resistance through a combinatorial strategy.

Journal: bioRxiv : the preprint server for biology

Published: December 25, 2025

Transcriptional Regulation of Protein Synthesis by Mediator Kinase Represents a Therapeutic Vulnerability in MYC-driven Medulloblastoma.

Transcriptional Regulation of Protein Synthesis by Mediator Kinase Represents a Therapeutic Vulnerability in MYC-driven Medulloblastoma.

Journal: Research square

Published: November 22, 2024

Transcriptional regulation of protein synthesis by mediator kinase represents a therapeutic vulnerability in MYC-driven medulloblastoma.

Transcriptional regulation of protein synthesis by mediator kinase represents a therapeutic vulnerability in MYC-driven medulloblastoma.

Journal: Nature communications

Published: October 24, 2024

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.

Journal: The Journal of clinical investigation

Published: May 01, 2024

Transcriptional Regulation of Protein Synthesis by Mediator Kinase in MYC-driven Medulloblastoma.

Transcriptional Regulation of Protein Synthesis by Mediator Kinase in MYC-driven Medulloblastoma.

Journal: bioRxiv : the preprint server for biology

Published: April 01, 2024

Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs.

Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs.

Journal: Nature genetics

Published: June 14, 2022

Effect of Heme Oxygenase-1 on Melanoma Development in Mice-Role of Tumor-Infiltrating Immune Cells.

Effect of Heme Oxygenase-1 on Melanoma Development in Mice-Role of Tumor-Infiltrating Immune Cells.

Journal: Antioxidants (Basel, Switzerland)

Published: October 29, 2020

SETBP1 overexpression acts in the place of class-defining mutations to drive FLT3-ITD-mutant AML.

SETBP1 overexpression acts in the place of class-defining mutations to drive FLT3-ITD-mutant AML.

Journal: Blood advances

Published: September 18, 2020

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.

Journal: The Journal of clinical investigation

Published: May 28, 2020

Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML.

Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML.

Journal: The Journal of experimental medicine

Published: July 06, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026